Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Tayaranian Marvian

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neuroscience Letters|February 19, 2019
The primary neuronal cells are more resistant than PC12 cells to α-synuclein toxic aggregatesMansooreh Heravi, Leila Dargahi, Soha Parsafar, et al.
Journal of Neurochemistry|April 21, 2019
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategiesAmir Tayaranian Marvian, David J Koss, Farhang Aliakbari, et al.
Journal of Food Science|September 10, 2015
Cuminaldehyde as the Major Component of Cuminum cyminum, a Natural Aldehyde with Inhibitory Effect on Alpha-Synuclein Fibrillation and CytotoxicityDina Morshedi, Farhang Aliakbari, Amir Tayaranian-Marvian, et al.
International Journal of Biological Macromolecules|October 6, 2016
Inhibition of lysozyme fibrillation by human serum albumin nanoparticles: Possible mechanismNegar Mirzazadeh Dizaji, Hossein Mohammad-Beigi, Farhang Aliakbari, et al.
The Protein Journal|August 8, 2015
Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 CellsMasoome Khalife, Dina Morshedi, Farhang Aliakbari, et al.
International Journal of Biological Macromolecules|April 3, 2020
The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillizationAmir Tayaranian Marvian, Farhang Aliakbari, Hossein Mohammad-Beigi, et al.
Nanoscale|November 10, 2015
Strong interactions with polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA NPs) alter α-synuclein conformation and aggregation kineticsHossein Mohammad-Beigi, Seyed Abbas Shojaosadati, Amir Tayaranian Marvian, et al.
Colloids and Surfaces. B, Biointerfaces|November 18, 2017
Formulation and anti-neurotoxic activity of baicalein-incorporating neutral nanoliposomeFarhang Aliakbari, Ali Akbar Shabani, Hassan Bardania, et al.
Nanoscale|May 5, 2018
The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's DiseaseFarhang Aliakbari, Hossein Mohammad-Beigi, Nasrollah Rezaei-Ghaleh, et al.
Progress in Neurobiology|June 26, 2019
Four-repeat tauopathiesThomas W Rösler, Amir Tayaranian Marvian, Matthias Brendel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neuroscience Letters|February 19, 2019
The primary neuronal cells are more resistant than PC12 cells to α-synuclein toxic aggregatesMansooreh Heravi, Leila Dargahi, Soha Parsafar, et al.
Journal of Neurochemistry|April 21, 2019
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategiesAmir Tayaranian Marvian, David J Koss, Farhang Aliakbari, et al.
Journal of Food Science|September 10, 2015
Cuminaldehyde as the Major Component of Cuminum cyminum, a Natural Aldehyde with Inhibitory Effect on Alpha-Synuclein Fibrillation and CytotoxicityDina Morshedi, Farhang Aliakbari, Amir Tayaranian-Marvian, et al.
International Journal of Biological Macromolecules|October 6, 2016
Inhibition of lysozyme fibrillation by human serum albumin nanoparticles: Possible mechanismNegar Mirzazadeh Dizaji, Hossein Mohammad-Beigi, Farhang Aliakbari, et al.
The Protein Journal|August 8, 2015
Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 CellsMasoome Khalife, Dina Morshedi, Farhang Aliakbari, et al.
International Journal of Biological Macromolecules|April 3, 2020
The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillizationAmir Tayaranian Marvian, Farhang Aliakbari, Hossein Mohammad-Beigi, et al.
Nanoscale|November 10, 2015
Strong interactions with polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA NPs) alter α-synuclein conformation and aggregation kineticsHossein Mohammad-Beigi, Seyed Abbas Shojaosadati, Amir Tayaranian Marvian, et al.
Colloids and Surfaces. B, Biointerfaces|November 18, 2017
Formulation and anti-neurotoxic activity of baicalein-incorporating neutral nanoliposomeFarhang Aliakbari, Ali Akbar Shabani, Hassan Bardania, et al.
Nanoscale|May 5, 2018
The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's DiseaseFarhang Aliakbari, Hossein Mohammad-Beigi, Nasrollah Rezaei-Ghaleh, et al.
Progress in Neurobiology|June 26, 2019
Four-repeat tauopathiesThomas W Rösler, Amir Tayaranian Marvian, Matthias Brendel, et al.
Pageof 1